Company Overview of NeuroPhage Pharmaceuticals, Inc.
NeuroPhage Pharmaceuticals, Inc. develops fusion-protein drug candidates or therapies for the treatment of chronic neurodegenerative diseases, amyloidoses, Alzheimer’s and Parkinson’s diseases, multiple orphan indications, and other protein misfolding diseases in patients. The company was founded in 2006 and is headquartered in Cambridge, Massachusetts.
222 Third Street
Cambridge, MA 02142
Founded in 2006
Key Executives for NeuroPhage Pharmaceuticals, Inc.
NeuroPhage Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
September 7, 2016
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact NeuroPhage Pharmaceuticals, Inc., please visit neurophage.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.